Prevalence of Aspergillus spp. in Patients Exhibiting Tuberculosis-like Symptoms in Yaoundé, Cameroon, and Analysis of Antifungal Resistance Patterns - Report - MDSpire

Prevalence of Aspergillus spp. in Patients Exhibiting Tuberculosis-like Symptoms in Yaoundé, Cameroon, and Analysis of Antifungal Resistance Patterns

  • By

  • Solange Meyin A. Ebong

  • Vigny Ndé Kengne

  • Moïse Ntah A. Ayong

  • Loick Pradel Kojom Foko

  • Juliette Lauryn Nga Ambono

  • Ghislaine Metsina Ndzana

  • Mélanie Togonodji Baïdam

  • Oben Youguitcha

  • Olivier Ziem A. Abah

  • Célestin Ayangma

  • Francioli Koro Koro

  • March 9, 2026

  • 0 min

Share

Clinical Report: Prevalence of Aspergillus spp. in Tuberculosis-like Symptoms

Overview

This study investigates the prevalence of Aspergillus spp. in patients with tuberculosis-like symptoms in Yaoundé, Cameroon, revealing a significant positivity rate and assessing antifungal resistance patterns. The findings highlight the critical need for accurate diagnosis to prevent mismanagement of pulmonary infections.

Background

Aspergillus spp. are opportunistic pathogens that can cause severe infections, particularly in immunocompromised individuals, such as those with tuberculosis. The overlap in clinical presentation between pulmonary aspergillosis and tuberculosis can lead to diagnostic errors, which is particularly concerning in regions with high tuberculosis prevalence. Understanding the prevalence and resistance patterns of Aspergillus spp. is essential for improving patient outcomes in affected populations.

Data Highlights

Remove placeholder text and include relevant data or state explicitly that no data is available.

Key Findings

  • Aspergillus spp. are frequently misdiagnosed in patients with tuberculosis-like symptoms.
  • Invasive aspergillosis is linked to high mortality rates, especially with azole-resistant strains.
  • Previous studies in Cameroon reported a 15% prevalence of Aspergillus in patients suspected of tuberculosis.
  • Co-infection with Aspergillus spp. is often overlooked in HIV-positive and HIV-negative patients.
  • Azole resistance in Aspergillus fumigatus poses significant treatment challenges in tuberculosis-endemic regions.

Clinical Implications

Clinicians should consider the possibility of pulmonary aspergillosis in patients presenting with tuberculosis-like symptoms, particularly in regions with high rates of both infections. Enhanced diagnostic protocols, including fungal testing, are necessary to ensure appropriate treatment and management.

Conclusion

Reiterate the importance of the study's findings and their implications for clinical practice.

References

  1. Infection — National Passive Surveillance of Fungal Infections Reveals Low Levels of Azole Resistance in Molds and Yeasts in Tyrol, Austria
  2. Infection — Case Study of Three Hematology Patients in Barcelona, Spain, with Azole-Resistant Aspergillus fumigatus Exhibiting TR34/L98H Mutation
  3. Infection — Trends in Drug Resistance Among Tuberculosis Patients: An Analysis of National Surveillance Data from Gabon, Central Africa
  4. Drugs - Real World Outcomes — Antimicrobial Resistance Trends in Bacterial Isolates from Urogenital Samples: A Descriptive Analysis from the Buea Health District, Cameroon
  5. A Systematic Review of Chronic Pulmonary Aspergillosis Among Patients Treated for Pulmonary Tuberculosis - PMC
  6. Azole resistance in Aspergillus spp. | EFSA
  7. A Systematic Review of Chronic Pulmonary Aspergillosis Among Patients Treated for Pulmonary Tuberculosis - PMC
  8. Azole resistance in Aspergillus spp. | EFSA

Original Source(s)

Related Content